Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

OsteoFlo HydroFiber Ambispective Evaluation

NCT: NCT07784673 · ENROLLING_BY_INVITATION

NCT IDNCT07784673
StatusENROLLING_BY_INVITATION
Start Date2026-09-01
Completion2027-02-01
SponsorSurGenTec LLC (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this observational, ambispective study is to collect real world patient outcomes to characterize the safety and effectiveness of OsteoFlo HydroFiber when used to promote fusion in the lumbar spine.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑